Search results
Dec 12, 2023 · Polycythaemia vera (PV) Polycythaemia vera (PV) is a rare blood cancer that affects the bone marrow. It is sometimes called erythrocytosis which means too many red blood cells. It is one of a group of conditions called myeloproliferative neoplasms or myeloproliferative disorders. Get more information on other myeloproliferative neoplasms.
Apr 6, 2023 · Polycythaemia vera (PV) is a rare blood cancer that affects the bone marrow. It causes your body to make too many red blood cells. You pronounce it as pol-ee-sigh-thee-me-a vee-rah. Poly means many and cythaemia relates to blood cells. White blood cells and platelets are also often increased with this condition.
Blood tests. The first test to diagnose polycythaemia vera (PV) is a blood test. This is to check: the number of red blood cells. the number of platelets. the number of white blood cells. the haematocrit level. The haematocrit level is the amount of space the red blood cells take up in the blood. When there are more red blood cells they take up ...
Research into Polycythaemia vera. Polycythaemia vera is part of a group of conditions called myeloproliferative neoplasms. They also include: myelofibrosis; essential thrombocythaemia; Researchers around the world are looking at better ways to treat polycythaemia vera and manage treatment side effects.
Apr 16, 2024 · The best available treatment for people with polycythaemia vera is hydroxycarbamide or peginterferon alfa 2a. But these treatments can stop working. Or you might have side effects that affect your quality of life. In these cases your doctor will try other treatments. Ruxolitinib is a targeted drug called a cancer growth blocker. It blocks ...
Polycythaemia vera (PV) is a condition where the bone marrow makes too many red blood cells. Essential thrombocythaemia (ET) is a condition where the bone marrow makes too many blood clotting cells (platelets). They are both classed as a myeloproliferative neoplasm (MPN). You may also hear the term myeloproliferative disorder (MPD).
Phase: Phase 1/2. This trial looked at a drug called givinostat to treat a blood disorder called polycythaemia vera. Polycythaemia vera is a myeloproliferative disorder . This means a condition in which the bone marrow produces too many blood cells. In polycythaemia, this is too many red blood cells . This trial was open for people to join ...
Read more about A trial comparing ruxolitinib with best available treatment for polycythaemia vera (MITHRIDATE) A study looking at tamoxifen for people with myeloproliferative disorders (TAMARIN) This study is for people with a type of blood disorder which causes the bone marrow to produce too many blood cells.
Nov 27, 2020 · Peginterferon alfa 2a is an immunotherapy drug. It is also known as Pegasys. You pronounce peginterferon alfa 2a as peg-in-ter-feer-on-al-far-2-a. It is a possible treatment for myeloproliferative disorders such as polycythaemia vera (PV) and essential thrombocythaemia (ET). It is also used to treat conditions other than cancer including ...
Jun 21, 2024 · Radioisotope therapy uses radioactive medicines to treat some types of cancer. It is also known as radionuclide therapy. You have the radioisotope as a drink, capsule or injection. You may need to follow some safety procedures when you have treatment with radioisotopes. This is to help protect others from being exposed to the radiation.
